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Abstract
Background: Recurrent abdominal cancer can manifest in many ways but there are certain
situations that are a great challenge to clinicians. Emergency presentation is one such situation.
Surgeons are faced with a therapeutic dilemma that on the one hand most of these patients have a
limited life expectancy, and on the other surgical procedures are unavoidable. We reviewed our
experience of recurrent abdominal cancers presenting with acute abdominal symptoms requiring
emergency.
Patients and methods: Over the last 10 years, 81 patients with recurrent abdominal cancer
presented with an abdominal emergency. Case records, operative notes and histology were
reviewed. Frequency distributions were prepared for clinical, hematological, biochemical
parameters, treatment and complications. Surgical analysis was carried out by the Kaplan Meier
method and groups were compared using a log-rank test.
Results: The mean age of the patients was 70.1 years with a female to male ratio of 1.25. An overall
postoperative mortality of 11.1% and morbidity of 27.1% was observed. Postoperative infections
and respiratory complications were the most common causes of morbidity and mortality.
Emergency resections carried the same risk of mortality and morbidity as the other surgical
procedures (p > 0.05). Patients who underwent radical or palliative resections had a better survival
than patients undergoing other procedures (p < 0.05). Preoperative Apache II score was found to
be single most important predictor of postoperative mortality and morbidity.
Conclusions: We conclude that surgical resection offers the best chance for improvement in
survival after emergency surgery for recurrent abdominal cancer. If resection is not feasible, the
possibility of creating a bypass or enterostomies should be considered to improve the patients'
quality of life.
Background
Recurrence in abdominal cancer can manifest in number
of ways, however, there are certain groups of patients that
present clinicians with a diagnostic and therapeutic chal-
lenge. Emergency surgical presentation is one such situa-
tion where the surgeon is faced with a therapeutic
dilemma. On the one hand, it is clear that most of these
patients may have a limited life expectancy, while, on the
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other, surgical intervention appears to be unavoidable in
these circumstances. The most common emergency surgi-
cal presentation is a bowel obstruction [1]. Other com-
mon presentations are perforations and bleeding.
These emergencies can be caused by a number of different
malignant neoplasms like gynecological cancers, colorec-
tal cancer, and stomach cancer etc. Malignant bowel
obstruction is a well-recognized complication in
advanced gynecological cancer but the most common
cause of intestinal obstruction is colorectal cancer [2].
Before the patient is taken up for surgery a preoperative
work-up for accurate staging and optimization for hema-
tological and biochemical derangements is essential. An
aggressive attitude leads to an increased resectability rates,
however a significant number of patients develop postop-
erative complications and thus results in significantly
increased morbidity and mortality [3].
Oncological operations as such carry a higher mortality
and morbidity than other standard abdominal proce-
dures. This risk is further increased in recurrent disease
and in emergency situations. Hence, to obtain the best
possible survival results the risk factors must be weighed
against possible benefits before deciding to operate on a
patient with emergency complication of abdominal can-
cer recurrence. Literature is abound with surgical resection
of recurrent abdominal cancers [4] however, the literature
on emergency presentation of recurrence is scarce. A
recent multidisciplinary working group of the European
Association of Palliative Care reviewed issues regarding
bowel obstruction and has published clinical practice rec-
ommendations for the management of bowel obstruction
in patients with terminal stage cancer [5].
The aim of the present study was to evaluate the mortality
and morbidity of emergency surgery in recurrent abdomi-
nal cancers and to identify the factors predicting the mor-
tality and morbidity.
Patients and methods
Between 1995 and 2004, 93 consecutive patients that
were admitted as an emergency as a result of recurrent
abdominal cancers to our department were retrospectively
evaluated. Of these 93 patients, 81(87%) were operated
on, whereas 12 were treated conservatively. This latter
group was excluded from the analysis and hence the final
sample comprised of 81 patients.
Clinical records, operative notes and histological exami-
nations were retrospectively reviewed. APACHE II scores
were calculated for all patients. All surgeries were per-
formed within 24 hours from admission. Majority of the
recurrences were from colon (32; 39.5%) followed by 13
(16 %) from stomach, 12 (14.8 %) from ovary, 8 (9.8%)
from uterus, 6 (7.4%) from bladder, 4 (4.9%) from gall-
bladder, 3 (3.7 %) from kidney, 2 (2.4%) retroperitoneal
sarcoma and one cancer of the anal canal.
The mean age was 70.1 years ranging from 48 to 96 years.
The female/male ratio was 1.25. All patients underwent a
detailed clinical examination followed by routine hema-
tological and biochemical work-up. An erect and supine
abdominal roentgenogram was obtained, followed by
staging work-up.
After a detailed laparotomy surgery including radical
resections or palliative resections (with documented
metastasis or residual tumor), or palliative by-pass, and
enterostomies were carried out.
The term radical resection was used when there was no
microscopic disease foci left behind otherwise it was clas-
sified as palliative. In presence of metastatic disease too
the resection was classified as palliative.
Postoperative morbidity, mortality (at 30 days) and sur-
vival after 2-year of follow-up was considered as end
points. These end points were examined in terms of gen-
der, cancer stage and type, symptoms, duration of symp-
toms, age, weight loss, mode of recurrence, anemia, serum
albumin and Apache II scores. Duration of operation,
blood loss, contamination, type of surgery and intra-oper-
ative transfusions were also considered. All the patients
received adjuvant treatment as per the institutional
protocol.
The statistical analysis was carried out using chi-square
test (Fisher exact test when appropriate), Student- New-
mann- Keuls test. Survival was estimated using Kaplan-
Meier method and differences in survival between groups
was estimated using long-rank test.
Results
Of the 81 patients treated by emergency surgery for recur-
rent abdominal cancer, 68 were obstructed, 10 were per-
forated and 3 subjects had an uncontrollable bleeding. A
high-degree of obstruction was present in 48 (70.5%)
patients. The preoperative Apache II score was higher than
10 in 66 subjects (81.4%). Patients who had undergone
non resective procedures had a poor Apache II score (18.9
± 2.6) compared to patients undergoing radical or pallia-
tive resections (10.6 ± 1.7; p < 0.05).
For the patients presenting with bleeding a colonoscopy
was performed but it failed to reach a diagnosis (1 patient
had an ileal bleeding and in the other cases there were
technical failures due to poor colon preparation).World Journal of Surgical Oncology 2004, 2:23 http://www.wjso.com/content/2/1/23
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Preoperative computed tomographic (CT) scan was per-
formed in 71 cases (87%), a recurrence was suspected in
majority of the patients, 55 (74%) of these had a palpable
abdominal mass. A total of 31 (38.2%) patients under-
went resections, 24 (29.6%) enterostomies, 15 (18.5%)
intestinal by-passes and 11 (13.5%) exploratory laparot-
omy alone. Of the 31 surgical resective procedures only 13
(16%) were radical. The overall morbidity was 27.1%,
while mortality was 11.1%. Univariate analysis of preop-
erative and operative factors affecting mortality and mor-
bidity are shown in table 1. The Apache II score was the
only statistically significant predictor affecting morbidity.
(p < 0.05). In all 9 patients died during 30-day postoper-
ative period of these 3 died of respiratory insufficiency
secondary to infection, 2 died from pulmonary embolism,
2 from multisystem organ failure and one each from acute
myocardial infection and abdominal sepsis leading to fis-
tula formation and death. The morbidity is detailed in
table 2. Pulmonary and wound infections were the most
common causes of morbidity, followed by intestinal
fistula and wound dehiscence. Emergency resections car-
ried the same risk of mortality and morbidity when com-
pared to other surgical procedures (>0.05) (Table 2).
The mean survival time was 21.3 months (95% CI 17.4–
24.8) in patients undergoing radical resection while it was
15.3 months (95% CI 11.8–18.9) in palliative resections
and 8 months (95% CI 6.1–9.8) for other procedures (p <
0.05). Patients who underwent radical and palliative
resections had a better 2-year survival when compared to
patients submitted to other surgical procedures (p < 0.05)
(Figure 1 and 2).
Discussion
Emergency surgery for abdominal cancer recurrence repre-
sents a challenge to surgeons.
Such operations are not only difficult they also carry a
higher morbidity and mortality than other standard
abdominal procedures [3]. Majority of these patients are
severely debilitated. About 80% of our patients had an
Apache II score of more than 10. Above all these patients
have an advanced cancer with a limited life expectancy,
and surgical intervention is unavoidable because of a life
threatening situation. What should be the best surgical
approach? Is an aggressive re-operative approach justi-
fied? What are the clinical risk factors affecting morbidity
and mortality? All these questions need be answered
before making a therapeutic decision. The extent of malig-
nant disease must be evaluated before surgery: the metas-
tastic disease often rules out a curative procedure.
Peritoneal carcinomatosis is often difficult to diagnosis by
imaging modalities and its presence too rules out a cura-
tive procedure.
Many authors suggest an aggressive surgical approach that
may lead to an increased resectability rate but a significant
number of patients will develop postoperative complica-
tions [4]. The effect of such an aggressive approach on the
long-term outcome too is not clear except in ovarian can-
cer [6]. Survival benefit of debulking surgery results from
radicality, avoidance of life threatening complications
and treatment of these complications if they occur. In our
series there were no differences in morbidity and mortal-
ity between resective (radical or palliative) and non resec-
tive procedures. Besides, survival was statistically better
for patients submitted to resective (radical and palliative)
procedures compared to non-resective procedures, even
though radical resection was possible only in few cases.
A selection bias is evidenced from the results as the sub-
jects were not randomized and patients with a limited dis-
ease have had a resective procedure. As a matter of fact the
difference observed in survival of this group of patients is
a reflection of the disease stage [7]. In the palliative resec-
tions group, the good result is probably due to the high
percentage of ovarian cancers where the role of debulking
surgery is well established [8]. As a matter of fact debulk-
ing operations for cancer are quite reasonable in order to
provide the optimum volume of cytoreduction and per-
form chemo- and radiation treatment [3]. Palliative
resection may also improve the quality of life by reducing
the danger of other complications such as obstruction,
bleeding and perforation. [9].
Endoscopic stents may be considered for palliation of
selected patients excluded from resective operations [10],
however, in an emergency setting it is not easy to decide
which patient is not suitable for resective procedures. Not
only in emergency setting but even other wise when a
recurrence is diagnosed palliative resection of the tumor is
indicated to improve the quality of the patient's remain-
ing life by reducing the danger of acute complications [5].
According to the results of the present series, there is no
difference in morbidity and mortality between bypass
procedures and enterostomies, even though enterosto-
mies seem to be somewhat safer. Nearly 14% of our cases
underwent laparotomies alone, the morbidity concerning
laparotomy is extremely high as these patients had very
poor general conditions due to the advanced unresectable
cancer. Laparoscopy may have a role under these
circumstances. Position emission tomography (PET) has
evolved as a useful strategy. Improved results can only be
expected if more effective and sensitive diagnostic modal-
ities are developed. However, in many cases even an
intensive follow-up may not affect the long-term outcome
of local recurrence [2].World Journal of Surgical Oncology 2004, 2:23 http://www.wjso.com/content/2/1/23
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Conclusions
To obtain the best survival for emergency surgery for
recurrent abdominal cancer, contributory risk factors such
as Apache II score must be weighed against possible
benefits when deciding to operate on a patient. Resective
surgery offers the best chance to improve survival in emer-
gency surgery in these circumstances. If resection is not
feasible, the possibility of creating a bypass or enteros-
tomy should be considered to improve the patient's qual-
ity of life. Resectable recurrent cancer carries a good
outlook. The surgeon must evaluate patient's conditions
to decide the extent of the operation [12].
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Table 1: Preoperative and operative factors affecting mortality and morbidity
Clinical Factor Subgroups Morbidity p Mortality p
Duration of symptoms < 1 day 12/ 42 (28.5%) n.s. 5/ 42 (11.9%) n.s.
1–3 days 6 /25 (24%) n.s. 3/ 25 (12%) n.s.
> 3 days 4/ 14 (28.5%) n.s. 1/ 14 (7.1%) n.s.
Gender Female 11/36 (30.5%) n.s. 3/36 (8.3%)
Male 11/45 (24.4%) 6/45 (13.3%)
Age < 50 yrs 3/ 12 (25%) n.s. 1/12 (8.3%) n.s.
51–70 yrs 7/ 28 (25%) n.s. 3/28 (10.7%) n.s.
> 70 yrs 12/ 41 (29.2%) n.s. 5/41 (12.1%) n.s.
Stage of the disease No residual Ca 3/13 (23%) 0/13
Residual Ca 19/68 (27.9 %) n.s. 9/68 (13.2%) n.s.
Mode of recurrence Local 9/36 (25%) n.s. 4/36 (11.1%) n.s.
Distant 8/30 (26.6%) n.s. 3/30 (10%) n.s.
Metastasis 5/15 (33.3%) n.s. 2/15 (13.3%) n.s.
Cancer type Colon 10/32 (31.2%) n.s. 5/32 (15.6%) n.s.
Stomach 4/13 (30.7%) n.s. 2/13 (15.3%) n.s.
Ovary 3/12 (25%) n.s 2/12 (16.6%) n.s
Uterus 2/8 (25%) n.s.
Bladder 2/6 (33.3%) n.s.
Gallbladder 1/4 (25%) n.s
Preoperative symptoms Obstruction 19/68 (27.9%) n.s. 7/68 (10.2%) n.s.
Perforation 2/10 (20%) n.s. 2/10 (20%) n.s.
Bleeding 1/3 (33.3%) n.s. 0/3 (0%) n.s.
Apache II score > 10 22/66 (33.3%) < 0.05 8/66 (12.1%) n.s.
< 10 0/15 1/15 (6.6%)
Loss of weight > 10 kg 8/25 (32%) n.s. 2/25 (8%) n.s.
< 10 kg 14/56 (25%) 7/56 (12.5%)
Preoperative albumin level < 2 mg/dL 9/28 (32.1%) n.s. 3/28 (10.7%) n.s.
> 2 mg/dL 13/53 (24.5%) 6/53 (11.3%)
Anemia < 10 mg/dL 9/29 (31%) n.s. 3/29 (10.3%) n.s.
> 10 mg/ dL 13/52 (25%) 6/52 (11.5%)
Operation time < 120 min. 10/34 (29.4%) n.s. 4/34 (11.7%) n.s.
> 120 min. 12/47 (25.5%) 5/47 (10.6%)
Blood loss > 500 cc 9/38 (23.6%) n.s. 4//38 (10.5%) n.s.
< 500 cc 13/43 (30.2%) 5/43 (11.6%)
Intraoperative transfusions Yes 19/70 (27.1%) n.s. 8/70 (11.4%) n.s.
No 3/11 (27.2%) 1/11 (9.0%)
Contamination Dirty 2/10 (20%) n.s. 1/10 (10%) n.s.
Contaminated 17/60 (28.3%) 7/60 (11.6%)
Clean 3/11 (27.2%) 1/11 (9%)
Operative Procedure Resections 7/31 (22.5%) n.s. 2/31 (6.4%) n.s.
Ex. Laparotomy 4/11 (36.3%) 2/11 (18.1%)
By-Pass 5/15 (33.3%) 2/15 (13.3%)
Enterostomy 6/24 (25%) 3/24 (12.5%)World Journal of Surgical Oncology 2004, 2:23 http://www.wjso.com/content/2/1/23
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